PURPOSE: The beta-adrenoceptor (beta-AR) plays an important role in heart failure. Recently, the new tracer (S)-[11C]CGP12388 has been developed. It displays excellent properties for investigation of the cardiac beta-ARs in vivo with positron emission tomography (PET). Furthermore, the simple production method allows its use in a routine clinical setting. The aim of this study was to investigate whether decreased myocardial beta-AR density in patients with idiopathic dilated cardiomyopathy (IDC) can be estimated using (S)-[11C]CGP12388 PET. METHODS: Myocardial beta-AR density was investigated in six patients with IDC and six age-matched healthy controls, using (S)-[11C]CGP12388 PET. RESULTS: Beta-AR densities of 5.4+/-1.3 pmol/g (mean +/- SD) were observed in patients; these values were significantly lower than those observed in healthy controls (8.4+/-1.5 pmol/g, p<0.005). CONCLUSION: This study indicates that PET with (S)-[11C]CGP12388 is applicable for the measurement of myocardial beta-AR density in patients. A highly significant reduction in beta-AR density was found in patients with IDC compared with healthy controls.
PURPOSE: The beta-adrenoceptor (beta-AR) plays an important role in heart failure. Recently, the new tracer (S)-[11C]CGP12388 has been developed. It displays excellent properties for investigation of the cardiac beta-ARs in vivo with positron emission tomography (PET). Furthermore, the simple production method allows its use in a routine clinical setting. The aim of this study was to investigate whether decreased myocardial beta-AR density in patients with idiopathic dilated cardiomyopathy (IDC) can be estimated using (S)-[11C]CGP12388 PET. METHODS: Myocardial beta-AR density was investigated in six patients with IDC and six age-matched healthy controls, using (S)-[11C]CGP12388 PET. RESULTS: Beta-AR densities of 5.4+/-1.3 pmol/g (mean +/- SD) were observed in patients; these values were significantly lower than those observed in healthy controls (8.4+/-1.5 pmol/g, p<0.005). CONCLUSION: This study indicates that PET with (S)-[11C]CGP12388 is applicable for the measurement of myocardial beta-AR density in patients. A highly significant reduction in beta-AR density was found in patients with IDC compared with healthy controls.
Authors: J Delforge; A Syrota; J P Lançon; K Nakajima; C Loc'h; M Janier; J M Vallois; J Cayla; C Crouzel Journal: J Nucl Med Date: 1991-04 Impact factor: 10.057
Authors: P H Elsinga; P Doze; A van Waarde; R M Pieterman; P K Blanksma; A T Willemsen; W Vaalburg Journal: Eur J Pharmacol Date: 2001-12-21 Impact factor: 4.432
Authors: M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson Journal: N Engl J Med Date: 1982-07-22 Impact factor: 91.245
Authors: L Brown; N M Deighton; S Bals; W Söhlmann; H R Zerkowski; M C Michel; O E Brodde Journal: J Cardiovasc Pharmacol Date: 1992-02 Impact factor: 3.105
Authors: Marilyn P Law; Stefan Wagner; Klaus Kopka; Christiane Renner; Victor W Pike; Otmar Schober; Michael Schäfers Journal: Nucl Med Biol Date: 2010-05 Impact factor: 2.408
Authors: Lars Stegger; Klaus Schäfers; Klaus Kopka; Stefan Wagner; Sven Hermann; Peter Kies; Marilyn Law; Otmar Schober; Michael Schäfers Journal: Eur Radiol Date: 2007-01-06 Impact factor: 5.315
Authors: Miran Kenk; James T Thackeray; Stephanie L Thorn; Karan Dhami; Benjamin J Chow; Kathy J Ascah; Jean N DaSilva; Rob S Beanlands Journal: J Nucl Cardiol Date: 2010-02-25 Impact factor: 5.952
Authors: Heike S Radeke; Ajay Purohit; Thomas D Harris; Kelley Hanson; Reinaldo Jones; Carol Hu; Padmaja Yalamanchili; Megan Hayes; Ming Yu; Mary Guaraldi; Mikhail Kagan; Michael Azure; Michael Cdebaca; Simon Robinson; David Casebier Journal: ACS Med Chem Lett Date: 2011-07-22 Impact factor: 4.345
Authors: R H J A Slart; R A Tio; P A van der Vleuten; T P Willems; D D Lubbers; R A Dierckx; D J van Veldhuisen Journal: J Nucl Cardiol Date: 2010-03-18 Impact factor: 5.952
Authors: Marilyn P Law; Stefan Wagner; Klaus Kopka; Victor W Pike; Otmar Schober; Michael Schäfers Journal: Eur J Nucl Med Mol Imaging Date: 2007-09-29 Impact factor: 9.236